go back

Revefenacin (Yupelri) Inhalation Solution

North Dakota rates for HCPCS J7677

Revefenacin inhalation solution, FDA-approved final product, noncompounded, administered through DME, 1 mcg

Rates data updated July 2026.

Facilitymedian $0 · 10th–90th $0$00%50%90th$0Professionalmedian $0 · 10th–90th $0$00%50%10th90th$0$0.0$0.1$0.5$2.0$10.0$50.0

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$0.20
Median
$0.20
Typical High
$0.36
Aetna
Setting
Professional
Modifier
Global
Typical Low
$0.20
Median
$0.20
Typical High
$0.24
BCBS
Setting
Facility
Modifier
Global
Typical Low
$0.21
Median
$0.21
Typical High
$0.21
BCBS
Setting
Professional
Modifier
Global
Typical Low
$0.16
Median
$0.21
Typical High
$0.22
Cigna
Setting
Professional
Modifier
Global
Typical Low
$0.19
Median
$0.19
Typical High
$0.23
Medica
Setting
Facility
Modifier
Global
Typical Low
$0.19
Median
$0.21
Typical High
$85.11
Medica
Setting
Professional
Modifier
Global
Typical Low
$0.19
Median
$0.19
Typical High
$0.21
United
Setting
Professional
Modifier
Global
Typical Low
$0.17
Median
$0.20
Typical High
$0.26